Apton Biosystems Competitors and Similar CompaniesClear all
BillionToOne's competitors and similar companies include HTG Molecular.
 BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. | ||
Founding Date | Founding Date 2016 | Founding Date 1997 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Menlo Park, US HQ | Locations Tucson, US HQ |
Employees | Employees 620 | Employees 31 |
Financial | ||
Revenue (est.) | Revenue (est.) $305.1m (FY, 2025) | Revenue (est.) $6.4m (FY, 2022) |
Cost of goods | Cost of goods $96.7m (FY, 2025) | Cost of goods $4.6m (FY, 2022) |
Gross profit | Gross profit $208.5m (FY, 2025) | Gross profit $1.8m (FY, 2022) |
Net income | Net income $7.5m (FY, 2025) | Net income ($21.6m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 87.5m | Total funding raised $ 69.7m |
For sources of this data, please see the company profile
View Company Profiles
HTG Molecular
HQ
Tucson, US
Employees
31
HTG Molecular Diagnostics is a company that specializes in precision medicine.
View company